These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


166 related items for PubMed ID: 25171752

  • 1. N-(4-[(18)F]-fluoropyridin-2-yl)-N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}carboxamides as analogs of WAY100635. New PET tracers of serotonin 5-HT(1A) receptors.
    García G, Abet V, Alajarín R, Álvarez-Builla J, Delgado M, García-García L, Bascuñana-Almarcha P, Peña-Salcedo C, Kelly J, Pozo MA.
    Eur J Med Chem; 2014 Oct 06; 85():795-806. PubMed ID: 25171752
    [Abstract] [Full Text] [Related]

  • 2. PET imaging of brain 5-HT1A receptors in rat in vivo with 18F-FCWAY and improvement by successful inhibition of radioligand defluorination with miconazole.
    Tipre DN, Zoghbi SS, Liow JS, Green MV, Seidel J, Ichise M, Innis RB, Pike VW.
    J Nucl Med; 2006 Feb 06; 47(2):345-53. PubMed ID: 16455642
    [Abstract] [Full Text] [Related]

  • 3. Design, synthesis and in vitro evaluation of bridgehead fluoromethyl analogs of N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}-N-(pyridin-2-yl)cyclohexanecarboxamide (WAY-100635) for the 5-HT(1A) receptor.
    Al Hussainy R, Verbeek J, van der Born D, Booij J, Herscheid JK.
    Eur J Med Chem; 2011 Dec 06; 46(12):5728-35. PubMed ID: 22000209
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and biologic evaluation of a novel serotonin 5-HT1A receptor radioligand, 18F-labeled mefway, in rodents and imaging by PET in a nonhuman primate.
    Saigal N, Pichika R, Easwaramoorthy B, Collins D, Christian BT, Shi B, Narayanan TK, Potkin SG, Mukherjee J.
    J Nucl Med; 2006 Oct 06; 47(10):1697-706. PubMed ID: 17015907
    [Abstract] [Full Text] [Related]

  • 5. First-in-human evaluation of 18F-mefway, a PET radioligand specific to serotonin-1A receptors.
    Hillmer AT, Wooten DW, Bajwa AK, Higgins AT, Lao PJ, Betthauser TJ, Barnhart TE, Rowley HA, Stone CK, Johnson SC, Mukherjee J, Christian BT.
    J Nucl Med; 2014 Dec 06; 55(12):1973-9. PubMed ID: 25453045
    [Abstract] [Full Text] [Related]

  • 6. Disulfiram inhibits defluorination of (18)F-FCWAY, reduces bone radioactivity, and enhances visualization of radioligand binding to serotonin 5-HT1A receptors in human brain.
    Ryu YH, Liow JS, Zoghbi S, Fujita M, Collins J, Tipre D, Sangare J, Hong J, Pike VW, Innis RB.
    J Nucl Med; 2007 Jul 06; 48(7):1154-61. PubMed ID: 17574977
    [Abstract] [Full Text] [Related]

  • 7. Comparison of 4 radiolabeled antagonists for serotonin 5-HT(7) receptor neuroimaging: toward the first PET radiotracer.
    Lemoine L, Andries J, Le Bars D, Billard T, Zimmer L.
    J Nucl Med; 2011 Nov 06; 52(11):1811-8. PubMed ID: 21990574
    [Abstract] [Full Text] [Related]

  • 8. Radiosynthesis and preclinical evaluation of 18F-F13714 as a fluorinated 5-HT1A receptor agonist radioligand for PET neuroimaging.
    Lemoine L, Becker G, Vacher B, Billard T, Lancelot S, Newman-Tancredi A, Zimmer L.
    J Nucl Med; 2012 Jun 06; 53(6):969-76. PubMed ID: 22577236
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Isoindol-1-one analogues of 4-(2'-methoxyphenyl)-1-[2'-[N-(2"-pyridyl)-p-iodobenzamido]ethyl]pipera zine (p-MPPI) as 5-HT1A receptor ligands.
    Zhuang ZP, Kung MP, Mu M, Kung HF.
    J Med Chem; 1998 Jan 15; 41(2):157-66. PubMed ID: 9457239
    [Abstract] [Full Text] [Related]

  • 12. 18F-F13640 preclinical evaluation in rodent, cat and primate as a 5-HT1A receptor agonist for PET neuroimaging.
    Vidal B, Fieux S, Colom M, Billard T, Bouillot C, Barret O, Constantinescu C, Tamagnan G, Newman-Tancredi A, Zimmer L.
    Brain Struct Funct; 2018 Jul 15; 223(6):2973-2988. PubMed ID: 29730825
    [Abstract] [Full Text] [Related]

  • 13. [18F]F15599, a novel 5-HT1A receptor agonist, as a radioligand for PET neuroimaging.
    Lemoine L, Verdurand M, Vacher B, Blanc E, Le Bars D, Newman-Tancredi A, Zimmer L.
    Eur J Nucl Med Mol Imaging; 2010 Mar 15; 37(3):594-605. PubMed ID: 19789870
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. N-oxide analogs of WAY-100635: new high affinity 5-HT(1A) receptor antagonists.
    Marchais-Oberwinkler S, Nowicki B, Pike VW, Halldin C, Sandell J, Chou YH, Gulyas B, Brennum LT, Farde L, Wikström HV.
    Bioorg Med Chem; 2005 Feb 01; 13(3):883-93. PubMed ID: 15653354
    [Abstract] [Full Text] [Related]

  • 16. Marmoset Serotonin 5-HT1A Receptor Mapping with a Biased Agonist PET Probe 18F-F13714: Comparison with an Antagonist Tracer 18F-MPPF in Awake and Anesthetized States.
    Yokoyama C, Mawatari A, Kawasaki A, Takeda C, Onoe K, Doi H, Newman-Tancredi A, Zimmer L, Onoe H.
    Int J Neuropsychopharmacol; 2016 Dec 01; 19(12):. PubMed ID: 27608810
    [Abstract] [Full Text] [Related]

  • 17. Radiochemical synthesis and tissue distribution of p-[18F]DMPPF, a new 5-HT1A ligand for PET, in rats.
    Defraiteur C, Lemaire C, Luxen A, Plenevaux A.
    Nucl Med Biol; 2006 Jul 01; 33(5):667-75. PubMed ID: 16843842
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evaluation of serotonin 5-HT(1A) receptors in rodent models using [¹⁸F]mefway PET.
    Saigal N, Bajwa AK, Faheem SS, Coleman RA, Pandey SK, Constantinescu CC, Fong V, Mukherjee J.
    Synapse; 2013 Sep 01; 67(9):596-608. PubMed ID: 23504990
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.